News | November 04, 2013

Viztek, Matakina Partner to Integrate Breast Density Assessment

Hospitals, imaging centers to benefit from streamlined reporting, workflow to assist with meeting breast density legislation

viztek, opal-wRIS,

Viztek Opal-wRIS

November 4, 2013 – Viztek announced a new partnership with Matakina to integrate the company’s VolparaDensity software for analyzing digital mammography and tomosynthesis images and objectively assessing breast density with the Viztek Opal-PACS and Opal-wRIS for streamlined reporting and workflow. With 12 states having enacted legislation requiring patient notification and reporting of breast density, hospitals and imaging centers can now benefit from a streamlined workflow and integrated reporting to meet these mandates and streamline patient care.

“Our integration with VolparaDensity extends our capabilities and enables us to provide a more complete women’s healthcare software suite,” said Steve Deaton, vice president at Viztek. “With viewing, tracking, and now breast density software integration for RIS and PACS, Viztek has the first complete package for mammography and is enabling increased efficiency with the potential for better results.”

Cleared by the FDA, HealthCanada, the TGA and CE-marked in Europe, VolparaDensity is in use at sites across the globe helping radiologists assess breast density more objectively and enabling them to better consider who might benefit from additional screening.  Highly correlated to breast MR assessments, VolparaDensity generates an objective, automatic measurement of volumetric breast density and an FDA-cleared BI-RADS breast density category.

“Creating an objective, reproducible value within the RIS/PACS workflow is critical, not only for efficiency in practice, but for meeting the demands of new breast density legislation,” explains David Mezzoprete, vice president of sales at Matakina. “Our partnership with Viztek establishes a new model for diagnosis and exam follow-up in this new era of regulated density reporting, and we are proud to play a role in enhancing patient care.” 

Studies have shown traditional FFDM is only 48 percent effective in women with dense breasts, who also happen to be more susceptible to cancer. The estimated 40 percent of women in the United States who have dense breasts may benefit from adjunctive imaging modalities, such as ultrasound, MRI or molecular breast imaging, which can provide a clearer view of potential “hidden” cancers.

With the Viztek and Matakina partnership, smooth RIS/PACS integration of density data provides a significant increase in efficiency and also will aid in objectivity. The VolparaDensity output is done via the secondary capture to the Viztek Opal-PACS and structured report to the Opal-wRIS. The RIS will then take the data and put it automatically into the patient “lay letter” for mammography reporting functionality and streamlined workflow for the facility.

For more information: www.viztek.net

Related Content

Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
Videos | Radiomics | August 09, 2018
A discussion with Martin Vallieres, Ph.D., post-doctoral fellow at McGill University, Montreal, Canada.
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...
Gary D. Luker Named Editor of Radiology: Imaging Cancer

Image courtesy of University of Michigan Medical School

News | Oncology Diagnostics | August 06, 2018
The Board of Directors of the Radiological Society of North America (RSNA) announced that Gary D. Luker, M.D., will...
Videos | Digital Radiography (DR) | August 03, 2018
Sheila Sferrella, president of Regents Health Resources and Bill Finerfrock, president of Capitol Associates, discuss
Videos | AAPM | August 03, 2018
Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke Un...
New Regulatory Approvals Driving Research and Development Dollars in Medical Imaging Artificial Intelligence
News | Artificial Intelligence | August 01, 2018
Medical imaging has become the bellwether for the application of artificial intelligence (AI) technologies, especially...
Overlay Init